These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20574853)

  • 1. [S3 guidelines on dementia. Symptomatic therapy of dementia].
    Frölich L
    Nervenarzt; 2010 Jul; 81(7):796-8, 800-2, 804-6. PubMed ID: 20574853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of Alzheimer's disease according to the S3 guidelines on dementia. Choline esterase inhibitors for all and for ever?].
    Lempert T; Bschor T
    Nervenarzt; 2011 Jan; 82(1):90-1; author reply 91-2. PubMed ID: 21274696
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evidence-based standards for care of patients with dementia. The interdisciplinary S3 guideline for dementia].
    Maier W; Jessen F
    Nervenarzt; 2010 Jul; 81(7):795. PubMed ID: 20585748
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
    Cumbo E; Ligori LD
    J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.
    O'Brien JT; Burns A;
    J Psychopharmacol; 2011 Aug; 25(8):997-1019. PubMed ID: 21088041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of recent dementia practice guidelines.
    Ngo J; Holroyd-Leduc JM
    Age Ageing; 2015 Jan; 44(1):25-33. PubMed ID: 25341676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia.
    Szeto JY; Lewis SJ
    Curr Neuropharmacol; 2016; 14(4):326-38. PubMed ID: 26644155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
    J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and emerging pharmacological treatment options for dementia.
    Ringman JM; Cummings JL
    Behav Neurol; 2006; 17(1):5-16. PubMed ID: 16720956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine].
    Sicras-Mainar A; Vergara J; Leon-Colombo T; Febrer L; Rejas-Gutierrez J
    Rev Neurol; 2006 Oct 16-31; 43(8):449-53. PubMed ID: 17033976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based guidelines--an introduction.
    Lim W; Arnold DM; Bachanova V; Haspel RL; Rosovsky RP; Shustov AR; Crowther MA
    Hematology Am Soc Hematol Educ Program; 2008; ():26-30. PubMed ID: 19074050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.
    Loveman E; Green C; Kirby J; Takeda A; Picot J; Payne E; Clegg A
    Health Technol Assess; 2006 Jan; 10(1):iii-iv, ix-xi, 1-160. PubMed ID: 16409879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antidementia Drug Therapy of Alzheimer's Dementia: Status 2018 and Outlook].
    Hausner L; Frölich L
    Dtsch Med Wochenschr; 2019 Feb; 144(3):156-160. PubMed ID: 30703832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidence based guidelines and clinical pathways: complementation or contradiction?].
    Lelgemann M; Ollenschläger G
    Internist (Berl); 2006 Jul; 47(7):690, 692-7. PubMed ID: 16763795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Care of patients in a catastrophe. Statement of the Interdisciplinary Working Group (IAP) of the German Interdisciplinary Association for Intensive Care Medicine and Emergency Medicine (DIVI)].
    Adams HA
    Unfallchirurg; 2006 Jul; 109(7):583-6. PubMed ID: 16773316
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescribing drugs for Alzheimer's disease in primary care: managing cognitive symptoms.
    Drug Ther Bull; 2014 Jun; 52(6):69-72. PubMed ID: 24924683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with psychotropic agents in patients with dementia and delirium : Gap between guideline recommendations and treatment practice].
    Hewer W; Thomas C
    Z Gerontol Geriatr; 2017 Feb; 50(2):106-114. PubMed ID: 28124100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cholinesterase inhibitors and Alzheimer's disease: meta-analysis of the verification of effectiveness, origin and bias of results in published studies].
    Egert S; Wagenpfeil S; Förstl H
    Dtsch Med Wochenschr; 2007 Jun; 132(22):1207-13. PubMed ID: 17520505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ABC of Alzheimer's disease: behavioral symptoms and their treatment.
    Grossberg GT
    Int Psychogeriatr; 2002; 14 Suppl 1():27-49. PubMed ID: 12636179
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.